comparative study of natural micronized progestrone and gonadotropin-releasing hormone agonist in the control of bleeding during hysterescopic myomectomy in women with abnormal uterine bleeding

Phase 1

Recruiting

• Conditions: Abnormal uterine and vaginal bleeding.; Other abnormal uterine and vaginal bleeding; ICD-10

• Registration Number: IRCT20110523006563N3
• Lead Sponsor: Vice chancellor for Research,Tabriz University Of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Patients with abnormal uterine bleeding
Patients with submucosal myoma with a diameter of 30 mm or less and zero or first grade

Exclusion Criteria

: Patients with a history of heart disease; Hepatic; Diabetes; Thromboembolism; Cancer of the uterus and cervix; Submucosal leiomyoma larger than 3 cm; Uterine septum; pregnant women; Severe bleeding; Anti coagulation therapy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The hemoglobin concentration. Timepoint: Six hours after surgery. Method of measurement: Blood test.

Secondary Outcome Measures

Name	Time	Method
Duration of surgery. Timepoint: After surgery. Method of measurement: Questionnaire.